Research Boehringer Ingelheim again rises up rare disease reputation rankingsBy Healthcare Propulsion StaffAugust 20, 20260 Boehringer Ingelheim has continued its rise up patient groups’ ranking of rare disease companies, adding to last year’s gains to…
